Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors
    6.
    发明申请
    Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors 审中-公开
    吡咯衍生物作为Dna促旋酶和拓扑异构酶抑制剂

    公开(公告)号:US20080161306A1

    公开(公告)日:2008-07-03

    申请号:US11816450

    申请日:2006-02-16

    申请人: Brian Sherer Fei Zhou

    发明人: Brian Sherer Fei Zhou

    CPC分类号: C07D207/34

    摘要: Compounds of formula (I) and their pharmaceutically acceptable salts are described: Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.

    摘要翻译: 还描述了式(I)化合物及其药学上可接受的盐:其制备方法,含有它们的药物组合物,其作为药物的用途及其在治疗细菌感染中的用途。

    HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF
    7.
    发明申请
    HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF 审中-公开
    杂环尿素衍生物及其使用方法

    公开(公告)号:US20090325902A1

    公开(公告)日:2009-12-31

    申请号:US12477800

    申请日:2009-06-03

    申请人: Brian Sherer Fei Zhou

    发明人: Brian Sherer Fei Zhou

    CPC分类号: C07D413/14

    摘要: Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.

    摘要翻译: 描述式(I)化合物及其药学上可接受的盐。 还描述了其制备方法,含有它们的药物组合物,它们作为药物的用途及其在治疗细菌感染中的用途。

    Reduce log contention by batching log record transfers to the log

    公开(公告)号:US10817500B2

    公开(公告)日:2020-10-27

    申请号:US14208958

    申请日:2014-03-13

    摘要: A system for managing database logging, the comprises a processor; and a user task executing in a database server process and executable by the processor, the user task to: receive in a database management system on a database server, a command to manipulate a portion of a database managed by the database management system; obtain a lock on the portion of the database; create a first log record in a first private log cache associated with the user task, the first log record recording a data manipulation to the portion of the database; enqueue the first log record to a queue; and release the lock on the portion of the database after copying the first log record to the queue.

    Method and apparatus for power supply control and electronic device
    9.
    发明授权
    Method and apparatus for power supply control and electronic device 有权
    电源控制和电子设备的方法和装置

    公开(公告)号:US09362769B2

    公开(公告)日:2016-06-07

    申请号:US14118987

    申请日:2012-05-23

    IPC分类号: H02J7/00 H01M10/44 G06F1/26

    摘要: The present invention provides a method and an apparatus for power supply control as well as an electronic device. The method comprises: detecting that the first device is connected with the second device via the first physical interface, when the first device is in the unconnected state; determining whether the connection between the first and second devices satisfies a first predetermined condition or not, so as to obtain a first determination result; switching the first device from the unconnected state to the first connected state when the first determination result indicates that the connection satisfies the first predetermined condition; obtaining power supply requirement information of the second device that indicates whether the first device is required to supply power to the second device or not; and controlling the power supply to the second device via the first physical interface based on the power supply requirement information.

    摘要翻译: 本发明提供一种用于电源控制的方法和装置以及电子装置。 该方法包括:当第一设备处于非连接状态时,检测第一设备经由第一物理接口与第二设备连接; 确定第一和第二装置之间的连接是否满足第一预定条件,以便获得第一确定结果; 当所述第一确定结果指示所述连接满足所述第一预定条件时,将所述第一设备从所述未连接状态切换到所述第一连接状态; 获取指示所述第二设备的电源需求信息是否需要向所述第二设备供电; 以及基于所述电源需求信息经由所述第一物理接口控制到所述第二设备的电力供应。

    Oxazolidinones as antibacterial agents
    10.
    发明授权
    Oxazolidinones as antibacterial agents 失效
    恶唑烷酮作为抗菌剂

    公开(公告)号:US07498350B2

    公开(公告)日:2009-03-03

    申请号:US10536687

    申请日:2003-11-24

    IPC分类号: A61K31/44 C07D413/00

    CPC分类号: C07D413/14

    摘要: A compound of the formula (I), or a pharmaceutically-acceptable salt, or in-vivo hydrolysable ester thereof: Wherein C is selected from (D) and (E), R2a, R6a, and R3a are independently selected from for example H, CF3, Me and Et; R2b and R6b are independently selected from for example H, F, CF3, Me and Et; R1b is for example optionally substituted diazolyl, triazolyl or tetrazolyl; R4 is for example an optionally substituted 5- or 6-membered heterocyclic ring system. Methods for making compounds of the formula (I), compositions containing them and their use as antibacterial agents are also described.

    摘要翻译: 式(I)化合物或其药学上可接受的盐或其体内可水解的酯:其中C选自(D)和(E),R 2a,R 6a和R 3a独立地选自例如H ,CF3,Me和Et; R2b和R6b独立地选自H,F,CF3,Me和Et; R 1b是例如任选取代的二唑基,三唑基或四唑基; R4是例如任选取代的5元或6元杂环系。 还描述了制备式(I)化合物,含有它们的组合物及其作为抗菌剂的用途的方法。